Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors

NCT02441062 is registered in ClinicalTrials.gov with Sue O'Dorisio as lead sponsor.

NCT NCT02441062
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02441062 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Ga-68 DOTATOC PET-CT Imaging in Management of Neuroendocrine Tumors
Lead sponsor
Sue O'Dorisio
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2015
Completion date
January 20, 2020
Enrollment
122 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoid tumors, medulloblastoma, neuroblastoma, neuroendocrine tumors